Effect of ranolazine on glycaemia in adults with and without diabetes: a meta-analysis of randomised controlled trials

BACKGROUND: Ranolazine is an antianginal drug reported to have hypoglycaemic effects. OBJECTIVES: To assess the effect of ranolazine versus placebo on glycaemic control for adults with and without diabetes. METHODS: A systematic search of seven databases was conducted to identify all randomised cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Teoh, Ik Hur, Banerjee, Moulinath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307613/
https://www.ncbi.nlm.nih.gov/pubmed/30613407
http://dx.doi.org/10.1136/openhrt-2017-000706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307613/
https://www.ncbi.nlm.nih.gov/pubmed/30613407
http://dx.doi.org/10.1136/openhrt-2017-000706

Ejemplares similares